Parplus Partners’s Johnson & Johnson JNJ Stock Holding History

Parplus Partners’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-1,400	Closed	-$204K	–	72
2019 Q4	$204K	Buy	+1,400	New	+$190K	0.04%	148

Other funds holding JNJ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Parplus Partners's JNJ Position: Q1 2020 in Review

Parplus Partners sold out of Johnson & Johnson (JNJ) in Q1 2020, closing a stake of 5,964 shares — an estimated $870K sold.

Parplus Partners first reported a position in JNJ in Q4 2019 and held it in 1 quarter. The position peaked at $870K in Q4 2019. 2,932 funds tracked by Wall St. Rank hold JNJ as of Q1 2020.

Parplus Partners reported no remaining Johnson & Johnson position as of Q1 2020 after selling out during the quarter.
Parplus Partners sold 5,964 Johnson & Johnson shares in Q1 2020, an estimated $870K.
Parplus Partners first reported a position in Johnson & Johnson in Q4 2019 and held it in 1 quarter.
Parplus Partners's Johnson & Johnson position peaked at $870K in Q4 2019.
2,932 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2020.

Based on Parplus Partners's 13F filing for Q1 2020, filed 14 May 2020.